Hong Kong Stock Movement | CStone Pharmaceuticals-B (02616.HK) rises nearly 4% on clinical development collaboration with Kimia to jointly advance a first-in-class potential drug
CStone Pharmaceuticals-B (02616.HK) rose nearly 4% intraday. As of press time, it was up 2.37% at HK$4.96, with a turnover of HK$8.2549 million.
Latest
